TET2 and myeloproliferative neoplasm: The order of acquisition in JAK2-mutated MPN with co-occurring mutation in TET2 impacts the disease phenotype and patients with JAK2 as first mutations have a higher risk of thrombosis and they have higher probability of presenting with PV than ET with an higher risk of thrombosis [56].